CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading researcher profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Andrew Worster - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Researchers/Profile

Researcher profile

Andrew Worster

OPENALEX: A5001357223↗ORCID: 0000-0001-7085-5061↗

Affiliations

Organizations

Canadian Centre on Substance Use and Addictionauthorship · CA Centre for Addiction and Mental Healthauthorship · CA Impactauthorship · CA McMaster Universityauthorship · CA

Public evidence

5 connected articles

Cannabis use and opioid relapse: An exploratory survival analysis of prospectively collected data.2022 · PubMed Central Open Access The association between cannabis use and outcome in pharmacological treatment for opioid use disorder.2021 · PubMed Central Open Access Cannabis use in patients treated for opioid use disorder pre- and post-recreational cannabis legalization in Canada.2021 · PubMed Central Open Access Association between cannabis use and methadone maintenance treatment outcomes: an investigation into sex differences.2017 · PubMed Central Open Access Sex differences in substance use, health, and social functioning among opioid users receiving methadone treatment: a multicenter cohort study2015 · PubMed Central Open Access

Registered research

Connected studies

Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trialnct07148206

Matched by exact identifiers only. Profile data: ORCID. Last retrieved 23/08/2026.